関連ニュース

Lonza Group AG (LZAGY) Analyst/Investor Day Transcript

H1 results showed 16% sales growth, a 44% net profit increase, and EBITDA margin expansion to 34.8%, driven by higher asset utilization and segment outperformance. Integrated Biologics, Advanced Synth